Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 1

1(25.0%)

Phase 3

1(25.0%)

4Total

N/A(2)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT05488041Not ApplicableUnknown

Anal Manometry Examination in Patients With Ulcerative Colitis

Role: collaborator

NCT04661930Phase 3Unknown

Fenofibrate for Patients With COVID-19 Requiring Hospitalization

Role: collaborator

NCT01238471Phase 1Completed

Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study

Role: collaborator

NCT01363193Not ApplicableUnknown

Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients

Role: lead

All 4 trials loaded